Replies to post #43313 on Relief Therapeutics Holding AG (RLFTF)

[Clef]

In reviewing the Justia patent link which you provided, I see 4 patents which are all expired. Further, all of these patents involved VIP which was extracted from animals. The aviptadil being used in the current clinical trials has synthetic sources. What, in your opinion, is SUNY licensing to NRXP, from these patents, that is relevant to the current clinical trials, FDA approvals, or the CA with RLFTF?